MP

Michael Prado

Cochlear Limited | Non-Executive Director
Mr Prado has more than 38 years' experience in the medical device and pharmaceutical industries. He brings experience in global strategy, healthcare innovation, commercialisation, international operations and organisational leadership, developed through senior executive roles across global markets. He held executive leadership positions with Johnson & Johnson across its medical device businesses in the US and served as Group Chairman of Ethicon, a global leader in medical devices and technologies focused on advancing surgical technologies and improving patient outcomes. Throughout his executive career, he was responsible for developing and executing global strategy, driving innovation and commercialisation. His international experience provides insight into global healthcare systems, evolving market dynamics, regulatory environments and strategic partnerships. Other boards incldue Director, Ambu A/S and a Member of the Board of Trustees of Franciscan University, Steubenville, Ohio. He was Co-lead Director, Verb Surgical. Advisory Board, Singapore Management University Lee Kong Chian School of Business. He is member of Medical Science Committee, People and Culture Committee, Product and Services Innovation Committee.

Company and Role

Company
Title
Tenure
Since
COH
Cochlear Limited
  • Non-Executive Director
4yrs, 7mthJan 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
COH
Cochlear Limited
24/08/261,504N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
COH
Cochlear Limited
24/08/26
Buy
412$96.750$39,861On-market trade
COH
Cochlear Limited
20/08/26
Buy
76$96.000$7,296On-market trade
COH
Cochlear Limited
28/08/25
Buy
75$200.000$15,000On-market trade
COH
Cochlear Limited
26/08/24
Buy
95$209.000$19,855On-market trade
COH
Cochlear Limited
14/11/23
Buy
117$169.214$19,798On-market trade